BOLT · Bolt Biotherapeutics, Inc.

$3.35 +0.14 (+4.36%) At close · Aug 14

Market Cap

$6.45M

1.93M

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-06-10	ONETTO NICOLE	Director	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.	Stock Option (Right to Buy)	5,000	—	—	5,000
2026-06-10	Berner Laura	Director	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.	Stock Option (Right to Buy)	5,000	—	—	5,000
2026-06-10	Dupont Jakob	Director	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.	Stock Option (Right to Buy)	5,000	—	—	5,000
2026-06-10	LAPORTE KATHLEEN	Director	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.	Stock Option (Right to Buy)	5,000	—	—	5,000
2026-06-10	O'CALLAGHAN BRIAN	Director	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.	Stock Option (Right to Buy)	5,000	—	—	5,000
2026-01-28	Yonehiro Grant	Chief Operating Officer	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2026.	Employee Stock Option (Right to Buy)	10,000	—	—	10,000
2026-01-28	Nemec Sarah	Senior VP, Finance and PAO	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2026.	Employee Stock Option (Right to Buy)	8,000	—	—	8,000
2026-01-28	Quinn William P.	Director, President, CEO and CFO	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2026.	Employee Stock Option (Right to Buy)	20,000	—	—	20,000
2025-12-12	Quinn William P.	Director, President, CEO and CFO	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price. For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024.	Employee Stock Option (Right to Buy)	21,999	—	—	21,999
2025-12-12	Dupont Jakob	Director	Other↓ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on September 3, 2024, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	849	—	—	0
2025-12-12	LAPORTE KATHLEEN	Director	Award↑ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on June 10, 2022, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	1,250	—	—	1,250
2025-12-12	O'CALLAGHAN BRIAN	Director	Other↓ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on March 24, 2022, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	1,810	—	—	0
2025-12-12	Yonehiro Grant	Chief Operating Officer	Other↓ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on January 18, 2017, in exchange for a new option having a lower price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	3,214	—	—	0
2025-12-12	Nemec Sarah	Senior VP, Finance and PAO	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price. For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024.	Employee Stock Option (Right to Buy)	2,499	—	—	2,499
2025-12-12	O'CALLAGHAN BRIAN	Director	Other↓ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price. The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.	Director Stock Option (Right to Buy)	1,100	—	—	0
2025-12-12	Quinn William P.	Director, President, CEO and CFO	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price. For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025.	Employee Stock Option (Right to Buy)	34,999	—	—	34,999
2025-12-12	LAPORTE KATHLEEN	Director	Award↑ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price. The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.	Director Stock Option (Right to Buy)	1,100	—	—	1,100
2025-12-12	Berner Laura	Director	Other↓ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on December 14, 2022, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	613	—	—	0
2025-12-12	Yonehiro Grant	Chief Operating Officer	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price. For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025.	Employee Stock Option (Right to Buy)	17,499	—	—	17,499
2025-12-12	Nemec Sarah	Senior VP, Finance and PAO	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	2,199	—	—	2,199
2025-12-12	ONETTO NICOLE	Director	Award↑ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on December 14, 2021, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	1,393	—	—	1,393
2025-12-12	Yonehiro Grant	Chief Operating Officer	Other↓ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price. For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024.	Employee Stock Option (Right to Buy)	7,749	—	—	0
2025-12-12	LAPORTE KATHLEEN	Director	Award↑ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on June 12, 2023, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	1,250	—	—	1,250
2025-12-12	Nemec Sarah	Senior VP, Finance and PAO	Other↓ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	2,199	—	—	0
2025-12-12	Yonehiro Grant	Chief Operating Officer	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on January 11, 2019, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	1,653	—	—	1,653
2025-12-12	Nemec Sarah	Senior VP, Finance and PAO	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on September 3, 2020, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	1,236	—	—	1,236
2025-12-12	Nemec Sarah	Senior VP, Finance and PAO	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on December 22, 2021, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	600	—	—	600
2025-12-12	Quinn William P.	Director, President, CEO and CFO	Other↓ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on March 4, 2024, in exchange for a new option having a lower exercise price. For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024.	Employee Stock Option (Right to Buy)	11,749	—	—	0
2025-12-12	Yonehiro Grant	Chief Operating Officer	Other↓ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on March 4, 2024, in exchange for a new option having a lower exercise price. For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024.	Employee Stock Option (Right to Buy)	11,749	—	—	0
2025-12-12	ONETTO NICOLE	Director	Other↓ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on June 12, 2024, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	1,100	—	—	0
2025-12-12	LAPORTE KATHLEEN	Director	Other↓ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on June 10, 2022, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	1,250	—	—	0
2025-12-12	Quinn William P.	Director, President, CEO and CFO	Other↓ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	10,499	—	—	0
2025-12-12	Yonehiro Grant	Chief Operating Officer	Other↓ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agree to cancellation of an option granted on January 17, 2018, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	660	—	—	0
2025-12-12	ONETTO NICOLE	Director	Award↑ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price. The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.	Director Stock Option (Right to Buy)	1,100	—	—	1,100
2025-12-12	Yonehiro Grant	Chief Operating Officer	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agree to cancellation of an option granted on January 17, 2018, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	660	—	—	660
2025-12-12	Yonehiro Grant	Chief Operating Officer	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on February 4, 2021, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	4,999	—	—	4,999
2025-12-12	O'CALLAGHAN BRIAN	Director	Other↓ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on June 10, 2022, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	1,250	—	—	0
2025-12-12	LAPORTE KATHLEEN	Director	Other↓ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on March 24, 2022, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	1,250	—	—	0
2025-12-12	Quinn William P.	Director, President, CEO and CFO	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	10,499	—	—	10,499
2025-12-12	Quinn William P.	Director, President, CEO and CFO	Other↓ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price. For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024.	Employee Stock Option (Right to Buy)	21,999	—	—	0
2025-12-12	Yonehiro Grant	Chief Operating Officer	Other↓ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on February 4, 2021, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	4,999	—	—	0
2025-12-12	Dupont Jakob	Director	Other↓ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price. The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.	Director Stock Option (Right to Buy)	1,100	—	—	0
2025-12-12	Dupont Jakob	Director	Award↑ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on September 3, 2024, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	849	—	—	849
2025-12-12	Quinn William P.	Director, President, CEO and CFO	Award↑ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on September 3, 2020, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	3,927	—	—	3,927
2025-12-12	O'CALLAGHAN BRIAN	Director	Award↑ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on June 10, 2022, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	1,250	—	—	1,250
2025-12-12	Yonehiro Grant	Chief Operating Officer	Other↓ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on April 4, 2018, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	822	—	—	0
2025-12-12	Berner Laura	Director	Other↓ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on December 14, 2022, in exchange for a new option having a lower exercise price. The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of December 14, 2022 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the three-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer.	Director Stock Option (Right to Buy)	2,500	—	—	0
2025-12-12	O'CALLAGHAN BRIAN	Director	Award↑ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on June 12, 2024, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	1,100	—	—	1,100
2025-12-12	Quinn William P.	Director, President, CEO and CFO	Other↓ Filing footnotes — Employee Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on February 4, 2021, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Employee Stock Option (Right to Buy)	5,000	—	—	0
2025-12-12	ONETTO NICOLE	Director	Award↑ Filing footnotes — Director Stock Option (Right to Buy) (Direct) The reporting person agreed to cancellation of an option granted on June 12, 2023, in exchange for a new option having a lower exercise price. The option is fully vested and exercisable.	Director Stock Option (Right to Buy)	1,250	—	—	1,250

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 323 transactions

Key facts CIK 1641281 Visit website Investor relations